{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:17:05Z","timestamp":1778858225541,"version":"3.51.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00424-026-03167-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:40:09Z","timestamp":1777437609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin converting enzyme-2 activation mitigates glucocorticoids-induced osteoporosis in rats by modulating oxidative stress, inflammation and the RANKL\/OPG pathway"],"prefix":"10.1007","volume":"478","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-039X","authenticated-orcid":false,"given":"Heba Fathy","family":"El-Domiaty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7138-2507","authenticated-orcid":false,"given":"Nesrin Abd Allah","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-8256","authenticated-orcid":false,"given":"Walaa Abdellah","family":"Esa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-335X","authenticated-orcid":false,"given":"Doaa Abdelsatar","family":"Madkour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-2480","authenticated-orcid":false,"given":"Eman I.","family":"Elgizawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"3167_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.endien.2022.01.005","volume":"69","author":"RAV Vargas","year":"2022","unstructured":"Vargas RAV, Mill\u00e1n JMV, Bonilla EF (2022) Renin\u2013angiotensin system: Basic and clinical aspects\u2014a general perspective. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.) 69(1):52\u201362. https:\/\/doi.org\/10.1016\/j.endien.2022.01.005","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"},{"key":"3167_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00774-020-01132-y","volume":"38","author":"C Mo","year":"2020","unstructured":"Mo C, Ke J, Zhao D, Zhang B (2020) Role of the renin\u2013angiotensin\u2013aldosterone system in bone metabolism. J Bone Miner Metab 38:772\u2013779. https:\/\/doi.org\/10.1007\/s00774-020-01132-y","journal-title":"J Bone Miner Metab"},{"issue":"7","key":"3167_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1271\/bbb.120123","volume":"76","author":"GU Sa-sa","year":"2012","unstructured":"-Sa-sa GU, Yan ZH, ANG, Xiao-li LI, Shu-yan WU, Teng-yue DIAO, Rong HAI, Hong-wen DEN (2012) Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice. Biosci Biotechnol Biochem 76(7):1367\u20131371. https:\/\/doi.org\/10.1271\/bbb.120123","journal-title":"Biosci Biotechnol Biochem"},{"key":"3167_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.774709","volume":"12","author":"B Pan","year":"2021","unstructured":"Pan B, Zheng L, Fang J, Lin Y, Lai H, Gao J, Pan W, Zhang Y, Ni K, Lou C, He D (2021) Azilsartan suppresses osteoclastogenesis and ameliorates ovariectomy-induced osteoporosis by inhibiting reactive oxygen species production and activating Nrf2 signaling. Front. Pharmacol 12:774709. https:\/\/doi.org\/10.3389\/fphar.2021.774709","journal-title":"Front. Pharmacol"},{"key":"3167_CR5","doi-asserted-by":"publisher","first-page":"174871","DOI":"10.1016\/j.ejphar.2022.174871","volume":"921","author":"X Liu","year":"2022","unstructured":"Liu X, Sun Y, Wei Q, Jiang W, Jiao M, Yan J, Wan C (2022) Captopril alleviates glucocorticoid-induced osteonecrosis of the femoral head by mediating the ACE2\/Ang-(1\u20137)\/Mas receptor cascade. Eur J Pharmacol 921:174871. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174871","journal-title":"Euro J Pharmacol"},{"issue":"10","key":"3167_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/abbs\/gmaa098","volume":"52","author":"H Tao","year":"2020","unstructured":"Tao H, Ge G, Liang X, Zhang W, Sun H, Li M, & Geng D (2020) ROS signaling cascades: dual regulations for osteoclast and osteoblast. Acta Biochimica et Biophysica Sinica. 52(10), 1055-1062.\u200f https:\/\/doi.org\/10.1093\/abbs\/gmaa098.","journal-title":"Acta Biochim Biophys Sin"},{"key":"3167_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00223-024-01257-6","volume":"115","author":"J Ren","year":"2024","unstructured":"Ren J, Kitaura H, Noguchi T et al (2024) Exogenous angiotensin-(1\u20137) provides protection against inflammatory bone resorption and osteoclastogenesis by inhibition of TNF-\u03b1 expression in macrophages. Calcif Tissue Int 115:432\u2013444. https:\/\/doi.org\/10.1007\/s00223-024-01257-6","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"3167_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono T, Hayashi M, Sasaki F, Nakashima T (2020) RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen 40(1):1\u201316. https:\/\/doi.org\/10.1186\/s41232-019-0111-3","journal-title":"Inflamm Regen"},{"issue":"1","key":"3167_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","volume":"39","author":"H Yasuda","year":"2021","unstructured":"Yasuda H (2021) Discovery of the RANKL\/RANK\/OPG system. J Bone Miner Metab 39(1):2\u201311","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"3167_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.5114\/aoms.2019.87410","volume":"15","author":"A Gonz\u00e1lez-Mercado","year":"2019","unstructured":"Gonz\u00e1lez-Mercado A, S\u00e1nchez-L\u00f3pez JY, Perea-D\u00edaz FJ, Maga\u00f1a-Torres MT, Salazar-P\u00e1ramo M, Gonz\u00e1lez-L\u00f3pez L, Gonz\u00e1lez-Mercado MG, Ibarra-Cort\u00e9s B (2019) Association of polymorphisms of the TNFRSF11B and TNFSF11 genes with bone mineral density in postmenopausal women from western Mexico. Arch Med Sci 15(5):1352\u20131356. https:\/\/doi.org\/10.5114\/aoms.2019.87410","journal-title":"Arch Med Sci"},{"issue":"2","key":"3167_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20200480","volume":"135","author":"J Kuriakose","year":"2021","unstructured":"Kuriakose J, Montezano AC, Touyz RM (2021) ACE2\/Ang-(1\u20137)\/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci 135(2):387\u2013407. https:\/\/doi.org\/10.1042\/CS20200480","journal-title":"Clin Sci"},{"issue":"1","key":"3167_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.22088\/IJMCM.BUMS.9.1.50","volume":"9","author":"A Sousa-Lopes","year":"2020","unstructured":"Sousa-Lopes A, de Freitas RA, Carneiro FS, Nunes KP, Allahdadi KJ, Webb RC, Lima VV (2020) Angiotensin (1\u20137) inhibits Ang II-mediated ERK1\/2 activation by stimulating MKP-1 activation in vascular smooth muscle cells. Int J Mol Cell Med 9(1):50\u201361. https:\/\/doi.org\/10.22088\/IJMCM.BUMS.9.1.50","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"3167_CR13","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1152\/ajpendo.00158.2020","volume":"320","author":"NN Sha","year":"2021","unstructured":"Sha NN, Zhang JL, Poon CCW, Li WX, Li Y, Wang YF, Zhang Y (2021) Differential responses of bone to angiotensin II and angiotensin (1\u20137): beneficial effects of ANG (1\u20137) on bone with exposure to high glucose. Am J Physiol Endocrinol Metab 320(1):E55\u201370. https:\/\/doi.org\/10.1152\/ajpendo.00158.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"3167_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/1440-1681.13251","volume":"47","author":"T Qaradakhi","year":"2020","unstructured":"Qaradakhi T, Gadanec LK, McSweeney KR, Tacey A, Apostolopoulos V, Levinger I, Zulli A (2020) The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clin Exp Pharmacol Physiol 47(5):751\u20138. https:\/\/doi.org\/10.1111\/1440-1681.13251","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3167_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115041","volume":"128","author":"CM Queiroz-Junior","year":"2019","unstructured":"Queiroz-Junior CM, Santos ACPM, Galv\u00e3o I, Souto GR, Mesquita RA, S\u00e1 MA, Ferreira AJ (2019) The angiotensin converting enzyme 2\/angiotensin-(1\u20137)\/Mas receptor axis as a key player in alveolar bone remodeling. Bone 128:115041. https:\/\/doi.org\/10.1016\/j.bone.2019.115041","journal-title":"Bone"},{"key":"3167_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-023-00673-1","volume":"10","author":"YH Habib","year":"2023","unstructured":"Habib YH, Sheta E, Khattab M, Gowayed MA (2023) Diminazene aceturate or losartan ameliorates the functional, radiological and histopathological alterations in knee osteoarthritis rodent model: repurposing of the ACE2\/Ang1-7\/MasR cascade. J Exp Orthop 10:107. https:\/\/doi.org\/10.1186\/s40634-023-00673-1","journal-title":"J Exp Orthop"},{"issue":"3","key":"3167_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031376","volume":"23","author":"CH Cheng","year":"2022","unstructured":"Cheng CH, Chen LR, Chen KH (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23(3):1376. https:\/\/doi.org\/10.3390\/ijms23031376","journal-title":"Int J Mol Sci"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","volume":"2020","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey E (2020) Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 2020:437\u2013447. https:\/\/doi.org\/10.1038\/s41574-020-0341-0","journal-title":"Nat Rev Endocrinol"},{"key":"3167_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12020-021-02723-z","volume":"74","author":"L Li","year":"2021","unstructured":"Li L, Bensing S, Falhammar H (2021) Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis. Endocrine 74:29\u201337. https:\/\/doi.org\/10.1007\/s12020-021-02723-z","journal-title":"Endocrine"},{"issue":"1","key":"3167_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1389450119666180405094046","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Yu X, He C (2019) Pro-inflammatory cytokines: cellular and molecular drug targets for glucocorticoid-induced-osteoporosis via osteocyte. Curr Drug Targets 20(1):1\u201315. https:\/\/doi.org\/10.2174\/1389450119666180405094046","journal-title":"Curr Drug Targets"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.03.002","volume":"70","author":"M Chen","year":"2023","unstructured":"Chen M, Fu W, Xu H, Liu CJ (2023) Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev 70:54\u201366. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.03.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"16","key":"3167_CR22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1080\/14656566.2016.1232390","volume":"17","author":"MC Van der Goes","year":"2016","unstructured":"Van der Goes MC, Strehl C, Buttgereit F, Bijlsma JW, Jacobs JW (2016) Can adverse effects of glucocorticoid therapy be prevented and treated? Expert Opin Pharmacother 17(16):2129\u201333. https:\/\/doi.org\/10.1080\/14656566.2016.1232390","journal-title":"Expert Opin Pharmacother"},{"key":"3167_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1140-y","volume":"16","author":"WG Hozayen","year":"2016","unstructured":"Hozayen WG, El-Desouky MA, Soliman HA, Ahmed RR, Khaliefa AK (2016) Antiosteoporotic effect of Petroselinum crispum, Ocimum basilicum and Cichorium intybus L. in glucocorticoid-induced osteoporosis in rats. BMC Complement Altern Med 16:165. https:\/\/doi.org\/10.1186\/s12906-016-1140-y","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"3167_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034647","volume":"7","author":"L Cui","year":"2012","unstructured":"Cui L, Li T, Liu Y, Zhou L, Li P, Xu B, Wu T (2012) Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenes. PLoS One 7(4):e34647. https:\/\/doi.org\/10.1371\/journal.pone.0034647","journal-title":"PLoS One"},{"issue":"4","key":"3167_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00223-014-9899-7","volume":"95","author":"S Lin","year":"2014","unstructured":"Lin S, Huang J, Zheng L, Liu Y, Liu G, Li N, Li G (2014) Glucocorticoid-induced osteoporosis in growing rats. Calcif Tissue Int 95(4):362\u201373. https:\/\/doi.org\/10.1007\/s00223-014-9899-7","journal-title":"Calcif Tissue Int"},{"issue":"16","key":"3167_CR26","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.7150\/ijms.48096","volume":"17","author":"IC Chen","year":"2020","unstructured":"Chen IC, Lin JY, Liu YC, Chai CY, Yeh JL, Hsu JH, Dai ZK (2020) The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction. Int J Med Sci 17(16):2594\u2013602. https:\/\/doi.org\/10.7150\/ijms.48096","journal-title":"Int J Med Sci"},{"key":"3167_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00210-023-02680-6","volume":"397","author":"F Shokri","year":"2024","unstructured":"Shokri F, Zarei M, Komaki A, Raoufi S, Ramezani-Aliakbari F (2024) Effect of diminazene on cardiac hypertrophy through mitophagy in rat models with hyperthyroidism induced by levothyroxine. Naunyn Schmiedebergs Arch Pharmacol 397:1151\u20131162. https:\/\/doi.org\/10.1007\/s00210-023-02680-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"3167_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/JMAU.JMAU_2_20","volume":"9","author":"A Mostafa","year":"2021","unstructured":"Mostafa A, Korayem HE, Fekry E, Hosny S (2021) The effect of intra-articular versus intravenous injection of mesenchymal stem cells on experimentally-induced knee joint osteoarthritis. Journal of Microscopy and Ultrastructure 9(1):31\u20138. https:\/\/doi.org\/10.4103\/JMAU.JMAU_2_20","journal-title":"Journal of Microscopy and Ultrastructure"},{"key":"3167_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01195","volume":"11","author":"Z Yan","year":"2020","unstructured":"Yan Z, Zhan J, Qi W, Lin J, Huang Y, Xue X, Pan X (2020) The protective effect of luteolin in glucocorticoid-induced osteonecrosis of the femoral head. Front Pharmacol 11:1195. https:\/\/doi.org\/10.3389\/fphar.2020.01195","journal-title":"Front Pharmacol"},{"key":"3167_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","volume":"30","author":"G Adami","year":"2019","unstructured":"Adami G, Saag K (2019) Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int 30:1145\u20131156. https:\/\/doi.org\/10.1007\/s00198-019-04906-x","journal-title":"Osteoporos Int"},{"issue":"2","key":"3167_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","volume":"47","author":"Z Yongtao","year":"2014","unstructured":"Yongtao Z, Kunzheng W, Jingjing Z, Hu S, Jianqiang K, Ruiyu L, Chunsheng W (2014) Glucocorticoids activate the local renin-angiotensin system in bone: a possible mechanism for glucocorticoid-induced osteoporosis. Endocrine 47(2):598\u2013608. https:\/\/doi.org\/10.1007\/s12020-014-0196-z","journal-title":"Endocrine"},{"issue":"S1","key":"3167_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s43465-023-01037-8","volume":"57","author":"SS Jha","year":"2023","unstructured":"Jha SS (2023) Glucocorticoid-induced osteoporosis (GIOP). Indian J Orthop 57(S1):181\u201391. https:\/\/doi.org\/10.1007\/s43465-023-01037-8","journal-title":"Indian J Orthop"},{"issue":"14","key":"3167_CR33","doi-asserted-by":"publisher","first-page":"11528","DOI":"10.18632\/oncotarget.23936","volume":"9","author":"S Liu","year":"2018","unstructured":"Liu S, Zhou L, Yang L, Mu S, Fang T, Fu Q (2018) Gastrodin alleviates glucocorticoid induced osteoporosis in rats via activating the Nrf2 signaling pathways. Oncotarget 9(14):11528\u201340. https:\/\/doi.org\/10.18632\/oncotarget.23936","journal-title":"Oncotarget"},{"key":"3167_CR34","doi-asserted-by":"publisher","unstructured":"Sangondimath G, Sen R (2023) DEXA and imaging in osteoporosis 57(1):182\u201393. https:\/\/doi.org\/10.1007\/s43465-023-01059","DOI":"10.1007\/s43465-023-01059"},{"issue":"6","key":"3167_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1138\/20110516","volume":"8","author":"R Sapir-Koren","year":"2011","unstructured":"Sapir-Koren R, Livshits G (2011) Bone mineralization and regulation of phosphate homeostasis. IBMS BoneKEy 8(6):286\u2013300. https:\/\/doi.org\/10.1138\/20110516","journal-title":"IBMS BoneKEy"},{"issue":"1","key":"3167_CR36","doi-asserted-by":"publisher","first-page":"G92","DOI":"10.1152\/ajpgi.00317.2006","volume":"292","author":"S Huybers","year":"2007","unstructured":"Huybers S, Naber THJ, Bindels RJM, Hoenderop JGJ (2007) Prednisolone-induced Ca2\u2009+\u2009malabsorption is caused by diminished expression of the epithelial Ca2\u2009+\u2009channel TRPV6. Am J Physiol Gastrointest Liver Physiol 292(1):G92\u20137. https:\/\/doi.org\/10.1152\/ajpgi.00317.2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"3167_CR37","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/jbmr.3761","volume":"34","author":"\u00c1 Delucchi","year":"2019","unstructured":"Delucchi \u00c1, Toro L, Alzamora R, Barrientos V, Gonz\u00e1lez M, Andaur R, Michea L (2019) Glucocorticoids decrease longitudinal bone growth in pediatric kidney transplant recipients by stimulating the FGF23\/FGFR3 signaling pathway. J Bone Miner Res 34(10):1851\u201361. https:\/\/doi.org\/10.1002\/jbmr.3761","journal-title":"J Bone Miner Res"},{"issue":"11","key":"3167_CR38","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jclinpath-2018-205130","volume":"72","author":"J Leung","year":"2019","unstructured":"Leung J, Crook M (2019) Disorders of phosphate metabolism. J Clin Pathol 72(11):741\u20137. https:\/\/doi.org\/10.1136\/jclinpath-2018-205130","journal-title":"J Clin Pathol"},{"issue":"1","key":"3167_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12291-010-0074-2","volume":"26","author":"VR Jagtap","year":"2011","unstructured":"Jagtap VR, Ganu JV, Nagane NS (2011) BMD and serum intact osteocalcin in postmenopausal osteoporosis women. Indian J Clin Biochem 26(1):70\u20133. https:\/\/doi.org\/10.1007\/s12291-010-0074-2","journal-title":"Indian J Clin Biochem"},{"issue":"3","key":"3167_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/art.20872","volume":"52","author":"N Leclerc","year":"2005","unstructured":"Leclerc N, Noh T, Khokhar A, Smith E, Frenkel B (2005) Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2\/Krox20-binding enhancer. Arthritis Rheum 52(3):929\u201339. https:\/\/doi.org\/10.1002\/art.20872","journal-title":"Arthritis Rheum"},{"key":"3167_CR41","doi-asserted-by":"publisher","unstructured":"Alazawi IS, Mohammed NS, Jassim NA (2016) Measuring of specific bone alkaline phosphatase (BAP) bone remodeling biomarker for post-COVID Iraqi patient. J Fac Med Bagdad 64. https:\/\/doi.org\/10.32007\/jfacmedbagdad.6441978","DOI":"10.32007\/jfacmedbagdad.6441978"},{"key":"3167_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00198-006-0286-8","volume":"18","author":"K Henriksen","year":"2007","unstructured":"Henriksen K, Tanko LB, Qvist P et al (2007) Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int 18:681\u2013685. https:\/\/doi.org\/10.1007\/s00198-006-0286-8","journal-title":"Osteoporos Int"},{"key":"3167_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17446651.2020.1772051","volume":"15","author":"I Chiodini","year":"2020","unstructured":"Chiodini I, Falchetti A, Merlotti D (2020) Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis. Expert Rev Endocrinol Metab 15:283\u201398. https:\/\/doi.org\/10.1080\/17446651.2020.1772051","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"3167_CR44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-014-2992-y","volume":"26","author":"B Shuai","year":"2015","unstructured":"Shuai B, Yang YP, Shen L, Zhu R, Xu XJ, Ma C, Rong JH (2015) Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients. Osteoporos Int 26(3):1063\u201371. https:\/\/doi.org\/10.1007\/s00198-014-2992-y","journal-title":"Osteoporos Int"},{"issue":"6","key":"3167_CR45","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3892\/etm.2017.4404","volume":"13","author":"L Shen","year":"2017","unstructured":"Shen L, Ma C, Shuai B, Yang Y (2017) Effects of 1, 25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis. Exp Ther Med 13(6):3297\u20133304. https:\/\/doi.org\/10.3892\/etm.2017.4404","journal-title":"Exp Ther Med"},{"key":"3167_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.11.003","volume":"363","author":"Y Wen","year":"2019","unstructured":"Wen Y, Shangguan Y, Pan Z, Hu H, Magdalou J, Chen L, Wang H (2019) Activation of local bone RAS by maternal excessive glucocorticoid participated in the fetal programing of adult osteopenia induced by prenatal caffeine exposure. Toxicol Appl Pharmacol 363:1\u201310. https:\/\/doi.org\/10.1016\/j.taap.2018.11.003","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"3167_CR47","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.3390\/ijms12074206","volume":"12","author":"XX Guan","year":"2011","unstructured":"Guan XX, Zhou Y, Li JY (2011) Reciprocal roles of angiotensin II and Angiotensin II Receptors Blockade (ARB) in regulating Cbfa1\/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis. Int J Mol Sci 12(7):4206\u201313. https:\/\/doi.org\/10.3390\/ijms12074206","journal-title":"Int J Mol Sci"},{"key":"3167_CR48","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biochi.2012.12.016","volume":"95","author":"K Nakai","year":"2013","unstructured":"Nakai K, Kawato T, Morita T, Iinuma T, Kamio N, Zhao N, Maeno M (2013) Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT (1) receptor in osteoblasts. Biochimie 95:922\u2013933. https:\/\/doi.org\/10.1016\/j.biochi.2012.12.016","journal-title":"Biochimie"},{"issue":"3","key":"3167_CR49","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5114\/aoms.2015.52369","volume":"11","author":"K Nakai","year":"2015","unstructured":"Nakai K, Kawato T, Morita T, Yamazaki Y, Tanaka H, Tonogi M, Maeno M (2015) Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17\/2.8 cells. Arch Med Sci 11(3):628\u2013637. https:\/\/doi.org\/10.5114\/aoms.2015.52369","journal-title":"Arch Med Sci"},{"issue":"8","key":"3167_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081238","volume":"10","author":"M Birk","year":"2021","unstructured":"Birk M, Baum E, Zadeh JK, Manicam C, Pfeiffer N, Patzak A, Gericke A (2021) Angiotensin II induces oxidative stress and endothelial dysfunction in mouse ophthalmic arteries via involvement of AT1 receptors and NOX2. Antioxidants 10(8):1238. https:\/\/doi.org\/10.3390\/antiox10081238","journal-title":"Antioxidants"},{"issue":"52","key":"3167_CR51","doi-asserted-by":"publisher","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","volume":"286","author":"M Almeida","year":"2011","unstructured":"Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC (2011) Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 286(52):44326\u201335. https:\/\/doi.org\/10.1074\/jbc.M111.283481","journal-title":"J Biol Chem"},{"issue":"1","key":"3167_CR52","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v4.i1.74","volume":"4","author":"S Mizuiri","year":"2015","unstructured":"Mizuiri S (2015) ACE and ACE2 in kidney disease. World J Nephrol 4(1):74. https:\/\/doi.org\/10.5527\/wjn.v4.i1.74","journal-title":"World J Nephrol"},{"issue":"9\u201310","key":"3167_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.drudis.2010.02.003","volume":"15","author":"L Shi","year":"2010","unstructured":"Shi L, Mao C, Xu Z, Zhang L (2010) Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. Drug Discov Today 15(9\u201310):332\u201341. https:\/\/doi.org\/10.1016\/j.drudis.2010.02.003","journal-title":"Drug Discov Today"},{"key":"3167_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117749","volume":"253","author":"HF Hasan","year":"2020","unstructured":"Hasan HF, Elgazzar EM, Mostafa DM (2020) Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by \u03b3-irradiation through boosting ACE2 signaling cascade. Life Sci 253:117749. https:\/\/doi.org\/10.1016\/j.lfs.2020.117749","journal-title":"Life Sci"},{"key":"3167_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-022-00584-4","volume":"23","author":"Z Lu","year":"2022","unstructured":"Lu Z, Wu D, Wang Z, Zhang H, Du Y, Wang G (2022) Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model. BMC Pharmacol Toxicol 23:44. https:\/\/doi.org\/10.1186\/s40360-022-00584-4","journal-title":"BMC Pharmacol Toxicol"},{"key":"3167_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115397","volume":"208","author":"LK Gadanec","year":"2023","unstructured":"Gadanec LK, Qaradakhi T, McSweeney KR, Matsoukas JM, Apostolopoulos V, Burrell LM, Zulli A (2023) Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels. Biochem Pharmacol 208:115397. https:\/\/doi.org\/10.1016\/j.bcp.2022.115397","journal-title":"Biochem Pharmacol"},{"key":"3167_CR57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.intimp.2019.04.023","volume":"72","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yang H, Chen B, Zhang R (2019) The skeletal renin-angiotensin system: a potential therapeutic target for the treatment of osteoarticular diseases. Int Immunopharmacol 72:258\u2013263. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.023","journal-title":"Int Immunopharmacol"},{"issue":"15","key":"3167_CR58","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2106\/JBJS.20.00989","volume":"103","author":"JS Kimball","year":"2021","unstructured":"Kimball JS, Johnson JP, Carlson DA (2021) Oxidative stress and osteoporosis. J Bone Joint Surg Am 103(15):1451\u201361. https:\/\/doi.org\/10.2106\/JBJS.20.00989","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"3167_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/1828051x.2021.1873706","volume":"20","author":"Y Wang","year":"2021","unstructured":"Wang Y, Salem AZM, Tan Z, Kang J, Wang Z (2021) Activation of glucocorticoid receptors is associated with the suppression of antioxidant responses in the liver of goats fed a high-concentrate diet. Ital J Anim Sci 20(1):195\u2013204. https:\/\/doi.org\/10.1080\/1828051x.2021.1873706","journal-title":"Ital J Anim Sci"},{"key":"3167_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111816","volume":"141","author":"T Hioki","year":"2021","unstructured":"Hioki T, Tokuda H, Kuroyanagi G, Kim W, Tachi J, Matsushima-Nishiwaki R, Kozawa O (2021) Olive polyphenols attenuate TNF-\u03b1-stimulated M-CSF and IL-6 synthesis in osteoblasts: suppression of Akt and p44\/p42 MAP kinase signaling pathways. Biomed Pharmacother 141:111816. https:\/\/doi.org\/10.1016\/j.biopha.2021.111816","journal-title":"Biomed Pharmacother"},{"key":"3167_CR61","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3892\/ijmm.2017.2892","volume":"39","author":"K Fujita","year":"2017","unstructured":"Fujita K, Tokuda H, Yamamoto N, Kainuma S, Kawabata T, Sakai G, Otsuka T (2017) Incretins amplify TNF-\u03b1-stimulated IL-6 synthesis in osteoblasts: suppression of the I\u03baB\/NF-\u03baB pathway. Int J Mol Med 39:1053\u20131060. https:\/\/doi.org\/10.3892\/ijmm.2017.2892","journal-title":"Int J Mol Med"},{"issue":"2","key":"3167_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/fcp.12845","volume":"37","author":"AM Abdelrahman","year":"2023","unstructured":"Abdelrahman AM, Ali BH, Ali H, Manoj P, Al-Suleimani Y (2023) The effect of diminazene, an angiotensin-converting enzyme 2 activator, on adenine\u2010induced chronic kidney disease in rats. Fundam Clin Pharmacol 37(2):235\u201344. https:\/\/doi.org\/10.1111\/fcp.12845","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"3167_CR63","first-page":"143","volume":"2","author":"FA Onyeachonam","year":"2022","unstructured":"Onyeachonam FA (2022) Review on therapeutic activities of diminazene aceturate. Journal of Sustainable Veterinary & Allied Sciences 2(2):143\u2013151","journal-title":"Journal of Sustainable Veterinary & Allied Sciences"},{"issue":"2","key":"3167_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/genes12020200","volume":"12","author":"S Abdi","year":"2021","unstructured":"Abdi S, Binbaz RA, Mohammed AK, Ansari M, Wani K, Amer OE, Al-Daghri NM (2021) Association of RANKL and OPG gene polymorphism in Arab women with and without osteoporosis. Genes 12(2):200. https:\/\/doi.org\/10.3390\/genes12020200","journal-title":"Genes"},{"key":"3167_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.903657","volume":"10","author":"L Marcadet","year":"2022","unstructured":"Marcadet L, Bouredji Z, Argaw A, Frenette J (2022) The roles of RANK\/RANKL\/OPG in cardiac, skeletal, and smooth muscles in health and disease. Frontiers in Cell and Developmental Biology 10:903657. https:\/\/doi.org\/10.3389\/fcell.2022.903657","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"3167_CR66","first-page":"18","volume":"28","author":"T Wang","year":"2022","unstructured":"Wang T, Li S, Yi C, Wang X, Han X (2022) Protective role of \u03b2-sitosterol in glucocorticoid-induced osteoporosis in rats via the RANKL\/OPG Pathway. Altern Ther Health Med 28(7):18\u201325 PMID: 35648689","journal-title":"Altern Ther Health Med"},{"issue":"2","key":"3167_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020426","volume":"13","author":"J Ren","year":"2025","unstructured":"Ren J, Marahleh A, Ma J, Ohori F, Noguchi T, Fan Z, Kitaura H (2025) Angiotensin II promotes osteocyte RANKL expression via AT1R activation. Biomedicines 13(2):426. https:\/\/doi.org\/10.3390\/biomedicines13020426","journal-title":"Biomedicines"},{"key":"3167_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14397595.2017.1369491","volume":"28","author":"S Tanaka","year":"2018","unstructured":"Tanaka S, Tanaka Y, Ishiguro N, Yamanaka H, Takeuchi T (2018) RANKL: a therapeutic target for bone destruction in rheumatoid arthritis. Mod Rheumatol 28:9\u201316. https:\/\/doi.org\/10.1080\/14397595.2017.1369491","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3167_CR69","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1359\/jbmr.051103","volume":"21","author":"NE Lane","year":"2006","unstructured":"Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Bonewald LF (2006) Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 21(3):466\u201376. https:\/\/doi.org\/10.1359\/jbmr.051103","journal-title":"J Bone Miner Res"},{"key":"3167_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jsbmb.2014.09.005","volume":"144","author":"M Feng","year":"2014","unstructured":"Feng M, Zhang R, Gong F, Yang P, Fan L, Ni J, Wang K (2014) Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats. J Steroid Biochem Mol Biol 144:455\u201362. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.09.005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"3167_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.21608\/adjalexu.2021.105598.1227","volume":"47","author":"A Sedik","year":"2022","unstructured":"Sedik A, Kawana K, Koura A, Mehanna R (2022) Biological effect of glucocorticoid administartion on the structure of alveolar bone. Alexandria Dent J 47(2):84\u201390","journal-title":"Alexandria Dent J"},{"key":"3167_CR72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rvsc.2021.04.025","volume":"37","author":"F Jia","year":"2021","unstructured":"Jia F, Zhang X, Ma W, Li X, Zhou X (2021) Cytotoxicity and anti-inflammatory effect of a novel diminazene aceturate derivative in bovine mammary epithelial cells. Res Vet Sci 37:102\u201310. https:\/\/doi.org\/10.1016\/j.rvsc.2021.04.025","journal-title":"Res Vet Sci"},{"issue":"1","key":"3167_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21865-2","volume":"12","author":"SH Yoon","year":"2022","unstructured":"Yoon SH, Kang HB, Kim J, Yoo K, Han SJ (2022) Diminazene aceturate attenuates hepatic ischemia\/reperfusion injury in mice. Sci Rep 12(1):18158. https:\/\/doi.org\/10.1038\/s41598-022-21865-2","journal-title":"Sci Rep"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-026-03167-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-026-03167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:43:56Z","timestamp":1778856236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-026-03167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s00424-026-03167-y","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper has been revised to correct inaccurate reference citations in the Discussion section.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}